Top Stories
Partnership aims to discover and develop candidates for neuroimmune disorders with an unmet need.
The company's Body Scan scale measures fat and muscle mass percentages, giving obesity care teams more insight into a patient's health than just their weight.
The deal gives Takeda's discovery teams direct access to Boltz's newest biomolecular foundation models, including BoltzMol-1 and BoltzProt-1.
The AI image generator is developing a new form of medical imaging called "ultrasonic CT," which it says can scan the entire body in just 60 seconds.
The NFX-led financing round gives Portal runway through 2028 as it expands beyond drug screening into AI data generation and continues working on a DARPA-backed cell therapy manufacturing platform.
Conference News
It's not just about the devices, but the data and what you do with it, Withings Health Solutions VP points out.
BERLIN--(BUSINESS WIRE)-- Pirche AG, a leader in digital molecular risk assessment, today announced a new collaboration to advance the field of transplant medicine and immunosuppression. In a strategi...
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical ManufacturingAGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic Thera...
CHICAGO – The American Society of Anesthesiologists (ASA) today announced Medtronic, a global leader in healthcare technology, has reaffirmed its commitment to ASA’s Corporate Supporter Program, conti...
Growing body of evidence supports AlloSure® as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomesData across kidney, heart, lung, and multi-organ transplantation...
